skip to main content

    Updated Visitor Guidelines

 

MENU

 

Rogel Cancer Center at the 2018 ASCO Annual Meeting

Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Clinical Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.

Immunotherapy cancer drugs may impact vision

Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.

Rogel Cancer Center at the American Society for Clinical Oncology Annual Meeting

Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Cancer Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.

Research in mice finds a pill could improve breast cancer diagnosis

As many as one in three women treated for breast cancer undergo unnecessary procedures, which is why it's important to find new ways to diagnose the disease. Research in mice finds a special kind of pill could do a better job distinguishing between benign and aggressive tumors.

Research Administrative Services

Matt Innes, MBA

Mathew H. Innes, MBA, interim associate director of administration
associate director for administration

Teleheath Video Visits

 

This clinic is not seeing patients at this time. Please call our Cancer AnswerLine™ at 800-865-1125 for information on who can help you with your survivorship questions.

CAR T-Cell Therapy

At the University of Michigan Rogel Cancer Center, we’re using the power of your immune cells to fight multiple myeloma and B-cell lymphomas with CAR T-cell therapy

If you are a patient, please talk with your oncologist or call 734-647-8902.

Physicians referring patients to the U-M Rogel Cancer Center for CAR T-cell therapy can contact M-LINE at 800-962-3555.

Rogel Cancer Center at the American Assocation for Cancer Research's Annual Meeting

Researchers from the University of Michigan Rogel Cancer Center will attend the American Assocation for Cancer Research Annual meeting from Sunday, April 14 through Wednesday, April 18. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.

Pages